Wealthcare Advisory Partners LLC Oragenics Inc Transaction History

Wealthcare Advisory Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$0.6 - $0.89 $3,000 - $4,450	-5,000 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$0.52 - $1.52 $2,600 - $7,600	5,000 New	5,000 $5,000
Q2 2020 Jul 29, 2020	SELL	$0.39 - $0.83 $1,950 - $4,150	-5,000 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$0.43 - $0.75 $2,150 - $3,750	5,000 New	5,000 $3,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.